Daito Pharmaceutical Co.,Ltd. (TYO:4577)

Market Cap	30.59B
Revenue (ttm)	48.84B
Net Income (ttm)	2.17B
Shares Out	29.99M
EPS (ttm)	70.93
PE Ratio	14.38
Forward PE	15.69
Dividend	35.00 (3.43%)
Ex-Dividend Date	May 29, 2025

Volume	58,300
Average Volume	99,435
Open	1,027.00
Previous Close	1,021.00
Day's Range	1,018.00 - 1,031.00
52-Week Range	970.00 - 2,302.00
Beta	0.08
RSI	50.20
Earnings Date	Jul 11, 2025

About Daito Pharmaceutical

Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. It offers generic drugs, active pharmaceutical ingredients, and over the counter drugs; and contract manufacturing services for formulations products, high-potent drugs, and packaging. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1942
• Employees: 1,070
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4577

Financial Performance

In 2024, Daito Pharmaceutical's revenue was 46.90 billion, an increase of 3.98% compared to the previous year's 45.10 billion. Earnings were 3.30 billion, a decrease of -8.47%.